文献速递妇科

弥散加权磁共振成像用于上皮性卵巢癌患者的术前评估

Diffusion-weighted magnetic resonance imaging for the pre-operative evaluation of epithelial ovarian cancer patients.
PubMed 文献 · Gynecol Oncol · 2023-05-17

本研究纳入2020年4月至2022年3月接受术前弥散加权磁共振成像(DWI/MR)检查并接受初次肿瘤细胞减灭术的80例疑似卵巢癌患者,采用Suidan标准进行R0切除预测评分。预测评分的受试者工作特征曲线下面积(AUC)为0.742(0.632-0.853);评分0-2、3-5、≥6分者的R0率分别为77.8%、62.5%和23.8%。作者认为DWI/MR是卵巢癌术前评估的充分技术,本研究中心认为预测评分0-5分的患者适合初次肿瘤细胞减灭术。

要点

  • 80例初次肿瘤细胞减灭术患者中97.5%为晚期(III-IV期),90.0%为高级别浆液性卵巢癌。
  • 预测评分中位数为4分(范围0-13),R0切除的AUC为0.742(0.632-0.853)。
  • 评分0-2、3-5、≥6分者的R0率分别为77.8%、62.5%和23.8%。

核心结论

  • DWI/MR是卵巢癌术前评估的充分技术,本研究中心认为预测评分0-5分的患者适合初次肿瘤细胞减灭术。

研究设计与样本

  • 前瞻性记录2020年4月至2022年3月间接受术前DWI/MR检查并接受初次肿瘤细胞减灭术的疑似卵巢癌患者数据。
  • 所有参与者按Suidan标准进行术前临床-影像学评估并计算预测评分。
  • 最终纳入80例接受初次肿瘤细胞减灭术的患者进行分析。

主要发现

  • 97.5%的患者为晚期(III-IV期),90.0%为高级别浆液性卵巢癌。
  • 46例(57.5%)达到无残留病灶(R0),27例(33.8%)达到肉眼残留病灶小于或等于1厘米的最佳肿瘤细胞减灭术(R1)。
  • BRCA1突变患者较野生型患者的R0切除率更低(42.9% vs 63.0%),R1切除率更高(50.0% vs 29.6%)。
  • 预测评分中位数为4分(范围0-13),R0切除的AUC为0.742(0.632-0.853)。
  • 预测评分0-2分、3-5分和≥6分患者的R0率分别为77.8%、62.5%和23.8%。

临床怎么用

  • 本研究中心的做法是:预测评分0-5分的患者适合初次肿瘤细胞减灭术。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the value diffusion-weighted magnetic resonance imaging (DWI/MR) in the selection of ovarian cancer patients suitable for primary debulking surgery. METHODS: Patients with suspected ovarian cancer who underwent pre-operative DWI/MR were enrolled between April 2020 and March 2022. All participants received preoperative clinic-radiological assessment according to the Suidan criteria for R0 resection with a predictive score. Data for patients with primary debulking surgery were prospectively recorded. The diagnostic value was calculated with ROC curves, and the cut-off value for the predictive score was also explored. RESULTS: 80 patients with primary debulking surgery were included in the final analysis. The majority (97.5%) of patients were at advanced stage (III-IV), and 90.0% of patients had high-grade serous ovarian histology. 46 (57.5%) patients had no residual disease (R0), and 27 (33.8%) patients had optimal debulking surgery with zzmacroscopic disease less than or equal to 1 cm (R1). Patients with BRCA1 mutation had lower R0 resection rate, higher R1 resection rate compared with wild-type patients (42.9% vs 63.0%, 50.0% vs 29.6%, respectively). The median (range) predictive score was 4 (0-13), and the AUC for R0 resection was 0.742 (0.632-0.853). The R0 rates for patients with predictive score 0-2, 3-5, and ≥ 6 were 77.8%, 62.5% and 23.8%, respectively. CONCLUSION: DWI/MR was a sufficient technique for pre-operative evaluation of ovarian cancer. Patients with predictive score 0-5 were suitable for primary debulking surgery at our institution.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Feng Z, Fu Y, Li R, et al. Diffusion-weighted magnetic resonance imaging for the pre-operative evaluation of epithelial ovarian cancer patients. Gynecol Oncol. 2023. PMID: 37207498. doi:10.1016/j.ygyno.2023.03.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。